Curaleaf Holdings (CURLF) Net Cash Flow (2019 - 2024)
Curaleaf Holdings (CURLF) recorded quarterly Net Cash Flow of $15.5 million in Q4 2024, up 537.11% quarter-over-quarter from $2.4 million in Q3 2024, and up 165.12% on a YoY basis from $5.9 million in Q1 2024.
Curaleaf Holdings (CURLF) Net Cash Flow (2019 - 2024) Analysis & Trends
Curaleaf Holdings' Net Cash Flow history runs 6 years deep, the most recent figure standing at $15.5 million for Q4 2024.
- In Q4 2024, Net Cash Flow rose 165.12% year-over-year to $15.5 million; the TTM figure through Sep 2025 stood at $15.5 million (up 165.56% YoY), while the FY2025 annual figure was -$5.0 million, down 131.75% from the prior year.
- Net Cash Flow was $15.5 million for Q4 2024 at Curaleaf Holdings, up from $2.4 million in the prior quarter.
- In the past five years, Net Cash Flow ranged from a high of $47.4 billion in Q2 2023 to a low of -$47.5 billion in Q1 2023.
- Historically, Net Cash Flow has averaged $12.8 million across 5 years, with a median of $1.2 million in 2020.
- Biggest YoY gain for Net Cash Flow was 246238.05% in 2023; the steepest drop was 116680.32% in 2023.
- A 5-year view of Net Cash Flow shows it stood at -$4.1 million in 2020, then tumbled by 355.73% to -$18.7 million in 2021, then jumped by 166.8% to $12.5 million in 2022, then plunged by 290.85% to -$23.9 million in 2023, then surged by 165.12% to $15.5 million in 2024.
- The last three Net Cash Flow figures came in at $15.5 million (Q4 2024), $2.4 million (Q3 2024), and -$41.9 billion (Q2 2024), per Business Quant data.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | NCF (Qtr) |
|---|---|---|---|---|---|
| 1 | Teva Pharmaceutical Industries | 38.34 Bn | 34.60 Bn | 1.97 Bn | 202.00 Mn |
| 2 | Zoetis | 33.27 Bn | 31.33 Bn | 1.62 Bn | -526.00 Mn |
| 3 | United Therapeutics | 23.75 Bn | 21.60 Bn | 648.10 Mn | -277.40 Mn |
| 4 | Aurora Cannabis | 17.11 Bn | 17.03 Bn | 33.43 Mn | - |
| 5 | Neurocrine Biosciences | 16.37 Bn | 15.05 Bn | 800.70 Mn | -446.50 Mn |
| 6 | Elanco Animal Health | 11.78 Bn | 11.35 Bn | 785.00 Mn | -112.00 Mn |
| 7 | Alkermes | 7.05 Bn | 6.54 Bn | -116.06 Mn | -768.22 Mn |
| 8 | Lantheus Holdings | 6.49 Bn | 5.99 Bn | 230.92 Mn | 139.49 Mn |
| 9 | Hims & Hers Health | 6.19 Bn | 5.44 Bn | 396.79 Mn | -3.97 Mn |
| 10 | Curaleaf Holdings | - | - | 157.29 Mn | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2024 | 15.54 Mn |
| Dec 31, 2024 | 15.54 Mn |
| Sep 30, 2024 | 2.44 Mn |
| Sep 30, 2024 | 2.44 Mn |
| Jun 30, 2024 | -41.93 Bn |
| Jun 30, 2024 | -41.93 Bn |
| Mar 31, 2024 | 41.93 Bn |
| Mar 31, 2024 | 41.93 Bn |
| Dec 31, 2023 | -23.86 Mn |
| Dec 31, 2023 | -23.86 Mn |
| Sep 30, 2023 | 31.71 Mn |
| Sep 30, 2023 | 31.71 Mn |
| Jun 30, 2023 | 47.40 Bn |
| Jun 30, 2023 | 47.40 Bn |
| Mar 31, 2023 | -47.48 Bn |
| Mar 31, 2023 | -47.48 Bn |
| Dec 31, 2022 | 12.50 Mn |
| Dec 31, 2022 | 12.50 Mn |
| Sep 30, 2022 | -26.01 Mn |
| Sep 30, 2022 | -26.01 Mn |